Sample-Index Misassignment Impacts Tumour Exome Sequencing

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Vodák, Daniel ^a,b   Lorenz, Susanne ^b   Nakken, Sigve ^b   Aasheim, Lars Birger ^b   Holte, Harald ^b,c,d   Bai, Baoyan ^c,d   Myklebost, Ola ^b,e   Meza Zepeda, Leonardo A ^b   Hovig, Eivind ^b,c,d  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ALLELE; DNA SEQUENCE; EXOME; GENE FREQUENCY; GENE LIBRARY; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; MEASUREMENT ACCURACY; NEOPLASM; PROCEDURES; SOFTWARE; WHOLE EXOME SEQUENCING;

ALGORITHMS; ALLELES; DATA ACCURACY; EXOME; GENE FREQUENCY; GENE LIBRARY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; SEQUENCE ANALYSIS, DNA; SOFTWARE; WHOLE EXOME SEQUENCING;

EID: 85044542142     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-23563-4     Document Type: Article

References (19)

1. Garraway, L. A. Genomics-Driven Oncology: Framework for an Emerging Paradigm. J. Clin. Oncol. 31, 1806-1814 (2013).
2. Griffith, M. et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat. Genet. 49, 170-174 (2017).
3. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013).
4. Ryu, D., Joung, J.-G., Kim, N. K. D., Kim, K.-T. &Park, W.-Y. Deciphering intratumor heterogeneity using cancer genome analysis. Hum. Genet. 135, 635-642 (2016).
5. Lee, J.-K., Choi, Y.-L., Kwon, M. &Park, P. J. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies. Annu. Rev. Pathol. 11, 283-312 (2016).
6. Cheng, D. T. et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. J. Mol. Diagn. 17, 251-264 (2015).
7. Zehir, A. et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23, 703-713 (2017).
8. Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413-421 (2012).
9. Alioto, T. S. et al. A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing. Nat. Commun. 6, 10001 (2015).
10. Chen, L., Liu, P., Evans, T. C. Jr. &Ettwiller, L. M. DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification. Science 355, 752-756 (2017).
11. Sinha, R. et al. Index Switching Causes 'Spreading-Of-Signal' Among Multiplexed Samples In Illumina HiSeq 4000 DNA Sequencing. bioRxiv 125724 (2017).
12. Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811-1817 (2012).
13. Bergmann, E. A., Chen, B.-J., Arora, K., Vacic, V. &Zody, M. C. Conpair: concordance and contamination estimator for matched tumor-normal pairs. Bioinformatics 32, 3196-3198 (2016).
14. Costello, M. et al. Characterization and remediation of sample index swaps by non-redundant dual indexing on massively parallel sequencing platforms. bioRxiv 200790 (2017).
15. Landau, D. A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714-726 (2013).
16. McGranahan, N. et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci. Transl. Med. 7, 283ra54 (2015).
17. Schmitt, M. W., Loeb, L. A. &Salk, J. J. The influence of subclonal resistance mutations on targeted cancer therapy. Nat. Rev. Clin. Oncol. 13, 335-347 (2016).
18. Li, H. &Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
19. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).